FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-8015com.
(The FASEB Journal. 2008;22:215-224.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.06-8015comv1
fj.06-8015comv2
22/1/215    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schildknecht, S.
Right arrow Articles by Bachschmid, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schildknecht, S.
Right arrow Articles by Bachschmid, M. M.
(The FASEB Journal. 2008;22:215-224.)
© 2008 FASEB

Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite

Stefan Schildknecht*, Andreas Daiber{dagger}, Sandro Ghisla{ddagger}, Richard A. Cohen* and Markus M. Bachschmid*,1

* Vascular Biology Unit, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, USA;

{dagger} Department of Cardiology, Johannes Gutenberg University, Mainz, Germany;

{ddagger} Department of Biochemistry, University of Konstanz, Konstanz, Germany

1Correspondence: Vascular Biology Unit, Department of Medicine, Boston University School of Medicine, 650 Albany St., X720, Boston, MA 02118, USA, E-mail: bach{at}bu.edu

The primary pharmacological target of acetaminophen is prostaglandin endoperoxide H2 synthase (PGHS). The enzymatic catalytic mechanism is radical-based, initiated, and maintained by the persistent presence of peroxides, particularly peroxynitrite, which is termed "peroxide tone". Whereas the prevailing concept assumes a direct reduction of the active, oxidized enzyme by acetaminophen, here we show that acetaminophen is a potent scavenger of peroxynitrite (peroxynitrite-mediated phenol nitration, IC50{approx}72µM; Sin-1-mediated DHR123 oxidation, IC50{approx}11µM) and thus inhibits PGHS by eliminating the peroxide tone. Nanomolar concentrations of peroxynitrite increased the activity of isolated PGHS and prostacyclin formation by aortic endothelial cells. This elevated activity was efficiently inhibited by pharmacologically relevant concentrations of acetaminophen (IC50{approx}10µM for 6-keto-PGF1{alpha}) and other free radical scavengers. However, when the peroxide tone was provided by H2O2 or tert-butyl-OOH, acetaminophen had only negligible inhibitory effects. Our concept could help to explain the efficacy of acetaminophen to inhibit PGHS in cell types with moderate oxidant formation. However, high levels of peroxynitrite or other peroxides such as lipid peroxides formed at inflammatory sites might overwhelm the ability of acetaminophen to decrease PGHS activation. The concept presented herein provides a molecular basis to explain the excellent analgesic and antipyretic properties of acetaminophen together with its minimal anti-inflammatory effects.—Schildknecht, S., Daiber, A., Ghisla, S., Cohen, R. A., Bachschmid, M. M. Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite.


Key Words: endothelium • cyclooxygenase • superoxide • nitric oxide • peroxide tone







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.